G. Kurz

发表

Arylsulfonamidothiazoles as a new class of potential antidiabetic drugs. Discovery of potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1.

L. Abrahmsén, E. Mosialou, T. Barf, 2002, Journal of medicinal chemistry.

Oxidative hydrolysis of scoparone by cytochrome p450 CYP2C29 reveals a novel metabolite.

C. Hagemeyer, R. Knoth, B. Volk, 2001, Biochemical and biophysical research communications.

Preclinical characterization of a potent and selective inhibitor of the histone demethylase KDM1A for MLL leukemia.

I. Tirapu, T. Maes, J. Castro-Palomino, 2013 .

Selective Inhibition of Trypanosomal Triosephosphate Isomerase by a Thiopeptide

F. Opperdoes, H. Matter, H. Kessler, 1992 .

JANUS WEDGES: a new approach towards nucleobase-pair recognition

J. Lehn, N. Branda, G. Kurz, 1996 .

Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases*

O. Rabal, J. Oyarzábal, J. Bischoff, 2009, The Journal of Biological Chemistry.

ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.

A. Melnick, C. Buesa, T. Somervaille, 2018, Cancer cell.

Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

Juan F. García, M. Piris, M. Sánchez-Beato, 2013, Haematologica.

Simultaneous pan-PI 3 K and MEK inhibition as a potential therapeutic strategy in peripheral T cell lymphomas

Juan F. García, M. Piris, M. Sánchez-Beato, 2012 .

Structure of a stereoregular phosphorothioate DNA/RNA duplex

G. Hessler, J. Hacia, P. Dervan, 1998, Nature Structural Biology.

Fragment-Hopping-Based Discovery of a Novel Chemical Series of Proto-Oncogene PIM-1 Kinase Inhibitors

Obdulia Rabal, Julen Oyarzabal, Joaquin Pastor, 2012, PloS one.